PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well ...

UK Societas ( ($GB:4BB) ) has provided an announcement. 4basebio has received Good Manufacturing Practice (GMP) certification from the ...

Wednesday that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines and Healthcare ...

PLC ("4basebio" or the "Company") 4basebio Receives GMP Licence for its UK DNA Manufacturing Facility. Cambridge, UK, 2 April 2025 – 4basebio PLC (AIM: 4BB), an innovat ...

In a report released on March 12, Charles Weston from RBC Capital maintained a Buy rating on 4basebio UK Societas (4BB – Research Report), with ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

4basebio PLC has a 1 year low of GBX 832.50 ($10.65) and a 1 year high of GBX 1,820 ($23.28). 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy ...

4basebio (AIM: 4BB) is an innovation driven life biotechnology company focused on accelerating the development of advanced therapy medicinal products (ATMPs) through its high-performance synthetic DNA ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

4basebio PLC has been granted Good Manufacturing Practice (GMP) certification by the UK’s Medicines and Healthcare products ...

3 March 2025 - 4basebio PLC (AIM: 4BB), which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, announces that it was informed on ...